Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Up 157.9% in March

Heart Test Laboratories, Inc. (NASDAQ:HSCSGet Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 506,000 shares, an increase of 157.9% from the February 29th total of 196,200 shares. Based on an average daily volume of 2,900,000 shares, the short-interest ratio is presently 0.2 days. Approximately 1.0% of the shares of the stock are sold short.

Heart Test Laboratories Stock Performance

Heart Test Laboratories stock opened at $0.12 on Friday. The stock has a market capitalization of $7.66 million, a P/E ratio of -0.24 and a beta of 3.44. Heart Test Laboratories has a 52 week low of $0.11 and a 52 week high of $1.49. The stock has a fifty day moving average of $0.13 and a 200-day moving average of $0.22.

Institutional Trading of Heart Test Laboratories

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Jane Street Group LLC acquired a new position in Heart Test Laboratories in the 2nd quarter valued at approximately $28,000. Vanguard Group Inc. bought a new position in Heart Test Laboratories during the fourth quarter worth $30,000. Renaissance Technologies LLC lifted its stake in shares of Heart Test Laboratories by 55.7% in the second quarter. Renaissance Technologies LLC now owns 35,350 shares of the company’s stock valued at $32,000 after buying an additional 12,650 shares in the last quarter. Astoria Strategic Wealth Inc. increased its holdings in Heart Test Laboratories by 246.1% during the 3rd quarter. Astoria Strategic Wealth Inc. now owns 81,995 shares of the company’s stock worth $35,000 after purchasing an additional 58,303 shares in the last quarter. Finally, Virtu Financial LLC raised its stake in shares of Heart Test Laboratories by 896.8% in the fourth quarter. Virtu Financial LLC now owns 255,382 shares of the company’s stock worth $44,000 after purchasing an additional 229,762 shares during the last quarter. 17.24% of the stock is currently owned by institutional investors.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

Featured Articles

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.